Viatris Inc.

Nasdaq VTRS · Canonsburg, PA

Works in Dermatology · ENT · Immunology · Infectious disease · Respiratory

Viatris Inc. is a clinical trial sponsor based in Canonsburg, PA, listed as Nasdaq VTRS. It has 3 active clinical trials with 175 planned participants, across 5 therapeutic areas. Since 2021 it has completed 1 trial and stopped 0 early. Its FDA record on file shows 1 inspection.

Trial track record · since 2021

3Active trials175 planned participants
1Completed0 with results posted
0Stopped earlyterminated, withdrawn or suspended

FDA record

1InspectionLatest 2026-05-18: Voluntary action indicated
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Financials · Nasdaq VTRS

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 3 active trials

StageTrialStatus

On the market

21 approved drug applications with a product on the market.

Questions about Viatris Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-15.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Viatris Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.